Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: In vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats

Fig. 1

Accumulation of urolithin metabolites in tissues of rats treated with UA or UB (n = 5 for each group). Control samples (CTRL and D3 groups) did not contain detectable levels of these metabolites. The fraction under each column accounts for the number of samples where the compound was detected. For Urolithin A and Urolithin B, the y axes on the right refer to the concentration of the two metabolites in the heart tissue. § p < 0.05 significant differences between D3-UA and D3-UB (Mann–Whitney U test). °Outlier values

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840